FindTrial
Sign In

Effect of goal-directed fluid therapy on the prognosis of pheochromocytoma resection

Effect of goal-directed fluid therapy on the prognosis of pheochromocytoma resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040684
Enrollment
Unknown
Registered
2020-12-08
Start date
2020-12-07
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pheochromocytoma

Interventions

experimental group:use Flotrac

Sponsors

Shengjing Hospital of China Medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Postoperative specimen pathology confirmed benign American Society of Anesthesiology (ASA) grades 1-3; 2. aged 18 to 75 years.

Exclusion criteria

Exclusion criteria: 1. family history of pheochromocytoma; 2. Laparoscopy converted to laparotomy; 3. Bilateral adrenal resection was performed; 4. A patient with ectopic pheochromocytoma.

Design outcomes

Primary

MeasureTime frame
Use time of booster after operation;Postoperative dose of booster drug;Postoperative hospitalization days;—

Countries

China

Contacts

Public ContactYali Zhao

Shengjing Hospital of China Medical University

1989046230@qq.com+86 17614044652

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026